{"name":"Disc Medicine, Inc","slug":"disc-medicine-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"DISC-0974","genericName":"DISC-0974","slug":"disc-0974","indication":"Other","status":"phase_2"},{"name":"DISC-3405","genericName":"DISC-3405","slug":"disc-3405","indication":"Other","status":"phase_2"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DISC-1459","genericName":"DISC-1459","slug":"disc-1459","indication":"Hereditary hemochromatosis","status":"phase_3"}]}],"pipeline":[{"name":"DISC-1459","genericName":"DISC-1459","slug":"disc-1459","phase":"phase_3","mechanism":"DISC-1459 is a hepcidin mimetic that increases hepcidin levels to reduce iron absorption and circulating iron, thereby treating iron overload disorders.","indications":["Hereditary hemochromatosis","Transfusion-dependent anemias with iron overload"],"catalyst":""},{"name":"DISC-0974","genericName":"DISC-0974","slug":"disc-0974","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"DISC-3405","genericName":"DISC-3405","slug":"disc-3405","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-06","type":"regulatory","source":"simplywall.st","summary":"Disc Medicine (IRON) Is Up 7.2% After Advancing Bitopertin Phase 3 Despite FDA Efficacy Concerns - simplywall.st","headline":"Disc Medicine (IRON) Is Up 7.2% After Advancing Bitopertin Phase 3 Despite FDA Efficacy Concerns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1iQWF2X19lME13QmttTWRSUUJqRlR2dnVfeGRsU2pOVnE5OXlqV0hhSnJaajNmYkhzVFh0T19YU2Z4TE9raHdWVDloc29KSXA5Q3FONXQ4eEtsNVBFZGxxM3lYRFlFV3J3a3NzV25xR3pCU2o1SGJXMTJoQQ?oc=5","date":"2026-04-06","type":"earnings","source":"The Business Journals","summary":"Biotech layoffs pick back up as 14 companies cut 745 jobs in Q1 - The Business Journals","headline":"Biotech layoffs pick back up as 14 companies cut 745 jobs in Q1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE54YTd6U0Z6bkhSVmR3cEFEd2lESjRaQjRpZU1paTR6T1dmQjVJTFJETkd3UXNSaGdja1NQbDFocDVaZHV0M0NyRThZT2REM1RWYldvMTJQanRiYS00NzEzVTB1Njl1bEpOQ19ST0x6cmUzTlRKZ2pOZDQtNnI?oc=5","date":"2026-03-31","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQY0QxeE43SFZJdHAwQ292UkFEekJTbEYxOERxdHc5ZXJQNkpxNFU0M3lmZHNJTWdvcWZ3Z3lyOTl5cU5BTmR6UVNLRjdhU0twYWROdHBkVHctT2EwZnB2X1lBUS00SEtvUUxPV1NETk9YUWJRczVHSkxNMVB2VGpvWWNjbHEtM05XUV92NDlnNjk4bEtYMXl2S3AwRUgtc2hpUEt0MWNPTDJvNDc5S2ZqN0dGcjcyeTRudFVSMFd1cF9QdDFBbnNRc0tzamwzS2ZsMUZoS203WHNSUFA2QmV3M2cxQQ?oc=5","date":"2026-02-17","type":"regulatory","source":"Reuters","summary":"Disc Medicine eyes standard US approval for drug after FDA denies fast-track nod - Reuters","headline":"Disc Medicine eyes standard US approval for drug after FDA denies fast-track nod","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPUkhmcklES0pPMjRSV0hEYS10TGEyNWxiSXRzNXU1UlhGaXhKVUtTSEdCcGZnNG5zRXpYa19lckNnZnhaYmhLOXFmSWNZNUQ1Wm1fOWpOdFFRRFpmc3dGbEZGS0RpVl9GSVZybzVfcVQzSE9oTGVybVVsSTI1QmJqWVFDdDJJRC1Q?oc=5","date":"2026-02-16","type":"regulatory","source":"pharmaphorum","summary":"FDA turns down 'national priority' drug from Disc Medicine - pharmaphorum","headline":"FDA turns down 'national priority' drug from Disc Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNQUVuZDVOTzhmSEMtUU41dzY0Sl9ZcnhITWFweDhxZEoycWVmZVlHcGltbW14cEF5YkhyNjdOM3hES2NMWTFvLVUxUkpjRk5udEpJcUE5dXVNS3A2S2J4WkZVVTg1VHlVWUlhNFlQcnotUFNXdjh5QWJac0hIMnRkdWwxSjFHLV8xenFrS0hNS1IzbXpheXBsa1ItQlF3Y19tYmJ3b2o0ZVV0UE5kRlZteS1kemZ0Ujh3QmdR?oc=5","date":"2026-02-16","type":"regulatory","source":"MedCity News","summary":"Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA - MedCity News","headline":"Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxORmVicTJreUQ5ZXFjbjktY1E1enJGTzQ2UDhpSVE5NVJQS1kybDNrQUo5M3J4cFdIU21uZ3hDcGhTaE93WWp0MFRVY2JUSjVlRHVJUUhRb0VNdER0Y1duQWk0RE0xNVdTQ1l0bzBSWDAxZDlJYlZHcXRVTXFYR3pIWXBRblU2N2ZFc2pMcmhXS0s0bmpKVHc?oc=5","date":"2026-02-14","type":"regulatory","source":"The Pharma Letter","summary":"FDA slaps CRL on Disc Medicine’s bitopertin NDA - The Pharma Letter","headline":"FDA slaps CRL on Disc Medicine’s bitopertin NDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFA2OF9hYTVHbnFaT0xlX3lkNHR2RHZEWGJ2Y1FpZExLSjZJYXBUdm04VUgwUllGOElXZFRRTVhXNkloNFpxY2V1SjJVY1NtSmhFTzRyQ3pB?oc=5","date":"2026-02-14","type":"pipeline","source":"Stock Titan","summary":"IRON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan","headline":"IRON Financials: Income Statement, Balance Sheet & Cash Flow","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQUlJfVnM0WGJ0RDVra1NBaVBuSERXclA4SWRPR1RuTlNobjNOLXhKYzVlSTVydUEyRnZPUUZUNXNZdWFKNEVBdzE5aUQyNFFwTHVuSV9KdDNIZUJ0LWxxMmtYa0lwckhBQi1LNUdqSGd3c1U4akNydkdiUFpsaVREVlVVaGlDcjlqZlFzX2hONkdwMFpLdmFpbGVfRU1EVGcxLUE2WmZNY0xoeTJTd2RFZWFPY1M2ZjE4SGZzejI4THY4NXNmalhn?oc=5","date":"2026-02-13","type":"regulatory","source":"Reuters","summary":"US FDA declines to approve Disc Medicine's rare disease drug - Reuters","headline":"US FDA declines to approve Disc Medicine's rare disease drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFB1OFlpTklkTFNlR1hIZ3czOVpZbGJDTXBialNMOHZaQkhWemJqQmJvZjFUeW5BNU1ZMFhuWlVKRjl1Xzh6YTR4eGk5RlE1S3l2VEVQSUVwUFJzaUxXZzZzZkJaM3pRSXNhWXhHLU1QU0JuVGdfeFc4?oc=5","date":"2026-01-16","type":"pipeline","source":"Hunt Scanlon Media","summary":"Klein Hersh Recruits CHRO for Disc Medicine - Hunt Scanlon Media","headline":"Klein Hersh Recruits CHRO for Disc Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNQ3FXb0hxWWNxeEhKXzFDZlNKQjhJcllCVEhjd2I0UVpJM0Q2c0M2WGduWU9ZdFNCM3JjRHI2OG0xc3RsTHlWc1hVUElYMi1Gcl9mYmd5M0FucGpyYTFmNzdxaEVXNEQwcmE3eWE5TWJncTZOMXNuYzJVZEhsTUlmQ2lkc3R3N05NU1Z1Rnc0V2xfTzV4VHJF?oc=5","date":"2025-10-31","type":"regulatory","source":"BioCentury","summary":"At least four PDUFA dates on FDA’s November docket - BioCentury","headline":"At least four PDUFA dates on FDA’s November docket","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":1,"phase_2":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}